| Symlin (pramlintide) / AstraZeneca |
FCL, NCT05199714: A Fully-closed Loop, Pramlintide and Insulin, Artificial Pancreas Clinical Trial for Adults With Type 1 Diabetes |
|
|
| Completed | N/A | 12 | Canada | Fiasp, Artificial Pancreas, Pramlintide, Aspart | McGill University Health Centre/Research Institute of the McGill University Health Centre, Juvenile Diabetes Research Foundation | Type 1 Diabetes | 03/23 | 03/23 | | |
| Recruiting | N/A | 20 | Europe | Pramlintide, Placebo (saline) infusion | Filip Krag Knop | Bone Diseases, Metabolic, Type 1 Diabetes | 08/24 | 08/24 | | |
NCT04243629: Co-administration of Pramlintide and Insulin Via an Automated Dual-hormone Artificial Pancreas System in Adults With Type 1 Diabetes |
|
|
| Recruiting | N/A | 26 | Canada | Rapid-Acting Insulin, Placebo, Pramlintide Acetate, Artificial Pancreas | McGill University, Canadian Institutes of Health Research (CIHR) | Diabetes Mellitus, Type 1, Type 1 Diabetes, Postprandial Hyperglycemia | 04/24 | 04/24 | | |
NCT06422325: Two Way Crossover Closed Loop Study Insulin vs Insulin and Pramlintide |
|
|
| Not yet recruiting | N/A | 35 | NA | MPC closed-loop system in insulin only mode, MPC closed-loop system in insulin/pramlintide mode | Oregon Health and Science University | Type 1 Diabetes | 11/24 | 12/24 | | |
NCT00691158: A Study of the Functional Magnetic Resonance Imaging Response to Leptin and Pramlintide |
|
|
| Active, not recruiting | N/A | 10 | US | Pramlintide (Amylin), Amylin, Placebo (Normal Saline), Placebo, 2 Metreleptin, Leptin, Leptin plus Pramlintide, Leptin and Amylin | Oregon Health and Science University | Obesity | 07/24 | 07/24 | | |
